These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 31072019)
1. Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells. Firuzi O; Che PP; El Hassouni B; Buijs M; Coppola S; Löhr M; Funel N; Heuchel R; Carnevale I; Schmidt T; Mantini G; Avan A; Saso L; Peters GJ; Giovannetti E Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31072019 [TBL] [Abstract][Full Text] [Related]
2. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment. Wong CW; Han HW; Tien YW; Hsu SH Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644 [TBL] [Abstract][Full Text] [Related]
3. Cellular context-dependent interaction between cancer and stellate cells in hetero-type multicellular spheroids of pancreatic tumor. Nam S; Khawar IA; Park JK; Chang S; Kuh HJ Biochem Biophys Res Commun; 2019 Jul; 515(1):183-189. PubMed ID: 31133378 [TBL] [Abstract][Full Text] [Related]
4. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells. Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372 [TBL] [Abstract][Full Text] [Related]
5. Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells. Hwang HJ; Oh MS; Lee DW; Kuh HJ J Exp Clin Cancer Res; 2019 Jun; 38(1):258. PubMed ID: 31200779 [TBL] [Abstract][Full Text] [Related]
6. Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells. Lenggenhager D; Amrutkar M; Sántha P; Aasrum M; Löhr JM; Gladhaug IP; Verbeke CS Cells; 2019 Jan; 8(1):. PubMed ID: 30621293 [TBL] [Abstract][Full Text] [Related]
7. Generation of an in vitro 3D PDAC stroma rich spheroid model. Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810 [TBL] [Abstract][Full Text] [Related]
8. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro. Xu J; Liu S; Yang X; Cao S; Zhou Y Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386 [TBL] [Abstract][Full Text] [Related]
9. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling. Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868 [TBL] [Abstract][Full Text] [Related]
10. Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and migration in pancreatic cancer cells. Tjomsland V; Aasrum M; Christoffersen T; Gladhaug IP Oncotarget; 2017 Sep; 8(42):71672-71684. PubMed ID: 29069737 [TBL] [Abstract][Full Text] [Related]
11. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance. Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547 [TBL] [Abstract][Full Text] [Related]
12. Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment. Giustarini G; Teng G; Pavesi A; Adriani G Front Oncol; 2023; 13():1156769. PubMed ID: 37519820 [TBL] [Abstract][Full Text] [Related]
13. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway. Chen ST; Kuo TC; Liao YY; Lin MC; Tien YW; Huang MC Oncogene; 2018 Nov; 37(46):6041-6053. PubMed ID: 29993037 [TBL] [Abstract][Full Text] [Related]
14. Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cells. Gao Y; Chen MK; Chu YY; Yang L; Yu D; Liu Y; Hung MC Am J Cancer Res; 2021; 11(1):236-250. PubMed ID: 33520371 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer. Avan A; Quint K; Nicolini F; Funel N; Frampton AE; Maftouh M; Pelliccioni S; Schuurhuis GJ; Peters GJ; Giovannetti E Curr Pharm Des; 2013; 19(5):940-50. PubMed ID: 22973962 [TBL] [Abstract][Full Text] [Related]
16. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors. Escorcia FE; Houghton JL; Abdel-Atti D; Pereira PR; Cho A; Gutsche NT; Baidoo KE; Lewis JS Theranostics; 2020; 10(1):151-165. PubMed ID: 31903112 [No Abstract] [Full Text] [Related]
17. Correlation between hypoxia and HGF/c-MET expression in the management of pancreatic cancer. Sharma R; Malviya R Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188869. PubMed ID: 36842767 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies. Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797 [TBL] [Abstract][Full Text] [Related]